Nirupama Ramadas; Erica Sparkenbaugh/LinkedIn
Nov 3, 2025, 04:56
Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
RPTH Journal shared on LinkedIn:
”Sickle cell disease (SCD) is more than a hemoglobinopathy, it’s a chronic thrombo-inflammatory disorder.
This review from Nirupama Ramadas and Erica Sparkenbaugh explores how hemolysis, endothelial activation, and cellular aggregates drive thrombosis, organ injury, and inflammation, and what that means for future therapies.
Read more.”
Read the full article in RPTH.
Article: Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis
Authors: Nirupama Ramadas, Erica Sparkenbaugh
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025